Andreas Halvorsen - Viking Global Investors
Holding/activity history for Human Genome Sciences Inc. (HGSI)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2010 Q4 | 0 | 0.00 | Sell 100.00% | 0.44 | SEC | ||
| 2010 Q3 | 1,042,121 | 0.44 | Add 1,578,871.21% | 0.44 | $29.79 | $31,044,000 | SEC |
| 2010 Q2 | 66 | 1.62 | Buy | 1.62 | $333.33 | $22,000 | SEC |
| 2006 Q2 | 0 | 0.00 | Sell 100.00% | 0.56 | SEC | ||
| 2006 Q1 | 1,443,000 | 0.56 | Add 67.40% | 0.23 | $10.87 | $15,685,000 | SEC |
| 2005 Q4 | 862,000 | 0.33 | Add 50.96% | 0.11 | $8.56 | $7,378,000 | SEC |
| 2005 Q3 | 571,000 | 0.37 | Buy | 0.37 | $13.59 | $7,759,000 | SEC |
| 2004 Q2 | 0 | 0.00 | Sell 100.00% | 2.92 | SEC | ||
| 2004 Q1 | 2,560,400 | 2.92 | Add 753.47% | 2.58 | $12.53 | $32,081,000 | SEC |
| 2003 Q4 | 300,000 | 0.46 | Buy | 0.46 | $13.25 | $3,975,000 | SEC |
| 2003 Q3 | 0 | 0.00 | Sell 100.00% | 1.06 | SEC | ||
| 2003 Q2 | 836,000 | 1.06 | Add 1.85% | 0.02 | $12.65 | $10,575,000 | SEC |
| 2003 Q1 | 820,800 | 0.59 | Buy | 0.59 | $8.55 | $7,017,000 | SEC |